Overcoming aromatase inhibitor resistance in breast cancer: possible mechanisms and clinical applications
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Overcoming aromatase inhibitor resistance in breast cancer: possible mechanisms and clinical applications
Authors
Keywords
Breast cancer, Aromatase inhibitor resistance, Estrogen, Androgen
Journal
Breast Cancer
Volume 25, Issue 4, Pages 379-391
Publisher
Springer Nature
Online
2017-04-07
DOI
10.1007/s12282-017-0772-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Biomarker Associations with Efficacy of Abiraterone Acetate and Exemestane in Postmenopausal Patients with Estrogen Receptor-Positive Metastatic Breast Cancer
- (2016) W. Li et al. CLINICAL CANCER RESEARCH
- PlasmaESR1Mutations and the Treatment of Estrogen Receptor–Positive Advanced Breast Cancer
- (2016) Charlotte Fribbens et al. JOURNAL OF CLINICAL ONCOLOGY
- Pictilisib for oestrogen receptor-positive, aromatase inhibitor-resistant, advanced or metastatic breast cancer (FERGI): a randomised, double-blind, placebo-controlled, phase 2 trial
- (2016) Ian E Krop et al. LANCET ONCOLOGY
- Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial
- (2016) Massimo Cristofanilli et al. LANCET ONCOLOGY
- PI3K inhibitors as new cancer therapeutics: implications for clinical trial design
- (2016) Cristian Massacesi et al. OncoTargets and Therapy
- Prevalence of ESR1 Mutations in Cell-Free DNA and Outcomes in Metastatic Breast Cancer
- (2016) Sarat Chandarlapaty et al. JAMA Oncology
- Contribution of Estrone Sulfate to Cell Proliferation in Aromatase Inhibitor (AI) -Resistant, Hormone Receptor-Positive Breast Cancer
- (2016) Toru Higuchi et al. PLoS One
- Abiraterone acetate, exemestane or the combination in postmenopausal patients with estrogen receptor-positive metastatic breast cancer
- (2015) J. O'Shaughnessy et al. ANNALS OF ONCOLOGY
- Fulvestrant with or without selumetinib, a MEK 1/2 inhibitor, in breast cancer progressing after aromatase inhibitor therapy: A multicentre randomised placebo-controlled double-blind phase II trial, SAKK 21/08
- (2015) Khalil Zaman et al. EUROPEAN JOURNAL OF CANCER
- Mechanisms of hormonal therapy resistance in breast cancer
- (2015) Shin-ichi Hayashi et al. International Journal of Clinical Oncology
- Revising the role of the androgen receptor in breast cancer
- (2014) F M Fioretti et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Increased androgen receptor activity and cell proliferation in aromatase inhibitor-resistant breast carcinoma
- (2014) Rika Fujii et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Everolimus Plus Exemestane in Postmenopausal Patients with HR+ Breast Cancer: BOLERO-2 Final Progression-Free Survival Analysis
- (2013) Denise A. Yardley et al. ADVANCES IN THERAPY
- Androgen metabolite-dependent growth of hormone receptor-positive breast cancer as a possible aromatase inhibitor-resistance mechanism
- (2013) Toru Hanamura et al. BREAST CANCER RESEARCH AND TREATMENT
- Possible role of the aromatase-independent steroid metabolism pathways in hormone responsive primary breast cancers
- (2013) Toru Hanamura et al. BREAST CANCER RESEARCH AND TREATMENT
- Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes
- (2013) Aleix Prat et al. BREAST CANCER RESEARCH AND TREATMENT
- Randomized Phase II, Double-Blind, Placebo-Controlled Study of Exemestane With or Without Entinostat in Postmenopausal Women With Locally Recurrent or Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Treatment With a Nonsteroidal Aromatase Inhibitor
- (2013) Denise A. Yardley et al. JOURNAL OF CLINICAL ONCOLOGY
- Estrogen Response element-GFP (ERE-GFP) introduced MCF-7 cells demonstrated the coexistence of multiple estrogen-deprivation resistant mechanisms
- (2013) Natsu Fujiki et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Final Overall Survival: Fulvestrant 500 mg vs 250 mg in the Randomized CONFIRM Trial
- (2013) A. D. Leo et al. JNCI-Journal of the National Cancer Institute
- Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, multicentre, phase 3 randomised trial
- (2013) Stephen RD Johnston et al. LANCET ONCOLOGY
- Proteomic Signatures of Acquired Letrozole Resistance in Breast Cancer: Suppressed Estrogen Signaling and Increased Cell Motility and Invasiveness
- (2013) Syreeta L. Tilghman et al. MOLECULAR & CELLULAR PROTEOMICS
- HDAC Inhibitor Entinostat Restores Responsiveness of Letrozole-Resistant MCF-7Ca Xenografts to Aromatase Inhibitors through Modulation of Her-2
- (2013) G. J. Sabnis et al. MOLECULAR CANCER THERAPEUTICS
- ESR1 ligand-binding domain mutations in hormone-resistant breast cancer
- (2013) Weiyi Toy et al. NATURE GENETICS
- Activating ESR1 mutations in hormone-resistant metastatic breast cancer
- (2013) Dan R Robinson et al. NATURE GENETICS
- Update on adjuvant hormonal treatment of early breast cancer
- (2011) Juan Lao Romera et al. ADVANCES IN THERAPY
- Targeting Androgen Receptor in Estrogen Receptor-Negative Breast Cancer
- (2011) Min Ni et al. CANCER CELL
- Sex steroid hormones in pairs of tumor and serum from breast cancer patients and pathobiological role of androstene-3β, 17β-diol
- (2011) Naoko Honma et al. CANCER SCIENCE
- Adaptive Changes Result in Activation of Alternate Signaling Pathways and Acquisition of Resistance to Aromatase Inhibitors
- (2011) A. Brodie et al. CLINICAL CANCER RESEARCH
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Steroid sulfatase inhibitors for estrogen- and androgen-dependent cancers
- (2011) Atul Purohit et al. JOURNAL OF ENDOCRINOLOGY
- Steroid sulfatase inhibitors: Promising new tools for breast cancer therapy?
- (2011) Jürgen Geisler et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Aromatase, aromatase inhibitors, and breast cancer
- (2011) Saranya Chumsri et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Steroid sulfatase: A pivotal player in estrogen synthesis and metabolism
- (2011) Atul Purohit et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- ER -Dependent E2F Transcription Can Mediate Resistance to Estrogen Deprivation in Human Breast Cancer
- (2011) T. W. Miller et al. Cancer Discovery
- Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers
- (2010) Isabella Castellano et al. BREAST CANCER RESEARCH AND TREATMENT
- Increased intratumoral androgens in human breast carcinoma following aromatase inhibitor exemestane treatment
- (2010) Kiyoshi Takagi et al. ENDOCRINE-RELATED CANCER
- Results of the CONFIRM Phase III Trial Comparing Fulvestrant 250 mg With Fulvestrant 500 mg in Postmenopausal Women With Estrogen Receptor–Positive Advanced Breast Cancer
- (2010) Angelo Di Leo et al. JOURNAL OF CLINICAL ONCOLOGY
- Adaptive changes results in activation of alternate signaling pathways and resistance to aromatase inhibitor resistance
- (2010) Gauri Sabnis et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Clinical perspectives on the utility of aromatase inhibitors for the adjuvant treatment of breast cancer
- (2009) Rowan Chlebowski et al. BREAST
- Characterization of the oestrogenic activity of non-aromatic steroids: are there male-specific endogenous oestrogen receptor modulators?
- (2009) Pan Wang et al. BRITISH JOURNAL OF PHARMACOLOGY
- Androgen Receptor Inhibits Estrogen Receptor- Activity and Is Prognostic in Breast Cancer
- (2009) A. A. Peters et al. CANCER RESEARCH
- Estrogen signaling pathway and its imaging in human breast cancer
- (2009) Shin-ichi Hayashi et al. CANCER SCIENCE
- In situestrogen production and its regulation in human breast carcinoma: From endocrinology to intracrinology
- (2009) Hironobu Sasano et al. PATHOLOGY INTERNATIONAL
- The androgen metabolite 5α-androstane-3β,17β-diol (3βAdiol) induces breast cancer growth via estrogen receptor: implications for aromatase inhibitor resistance
- (2008) Matthew J. Sikora et al. BREAST CANCER RESEARCH AND TREATMENT
- Combination of Anastrozole with Fulvestrant in the Intratumoral Aromatase Xenograft Model
- (2008) L. F. Macedo et al. CANCER RESEARCH
- Current research topics in endocrine therapy for breast cancer
- (2008) Hiroko Yamashita International Journal of Clinical Oncology
- Intracrinology of estrogens and androgens in breast carcinoma
- (2007) Hironobu Sasano et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now